| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0224 | 1-Azakenpaullone (1-Akp) | 676596-65-9 | 1-Azakenpaullone(1-Akp), an analog of kenpaullone, is a novel, ATP-competitive and selective inhibitor of GSK-3β (glycogen synthase kinase 3β) with potentialantidiabetic and neuroprotective activities. |
|
V0228 | BIO-acetoxime (GSK-3 Inhibitor X; BIA) | 667463-85-6 | BIO-acetoxime (also known asGSK-3 Inhibitor X;BIA),a synthetic derivative of a compound from the Mediterranean mollusk Hexaplex trunculus, is a novel, potent and selective dual inhibitor of GSK3α/β (glycogen synthase kinase-3) with potentialanti-infection andanticonvulsant as well as anticancereffects. |
|
V0220 | AZD1080 | 612487-72-6 | AZD1080 is a selective, potent,orally bioactive, and brain permeable GSK3 (glycogen synthase kinase-3) inhibitor with neuroprotective effects. |
|
V0219 | AZD2858 | 486424-20-8 | AZD2858 is a novel, potent, orally bioactive, and selective GSK-3 (glycogen synthase kinase-3) inhibitor with the potential to be used in fracture healing. |
|
V0213 | CHIR-98014 | 252935-94-7 | CHIR-98014 (also known as CT-98024) is a novel, potent, reversible, cell-permeable inhibitor of GSK-3 (glycogen synthase kinase-3) with potential anti-diabetic activity. |
|
V3531 | GSK-3 inhibitor 1 | 603272-51-1 | GSK-3 inhibitor 1 is a novel and potent inhibitor ofGSK-3 (Glycogen synthase kinase-3). |
|
V0221 | AR-A014418 (SN-4521; GSK 3β inhibitor VIII) | 487021-52-3 | AR-A014418 (AR 0133418; SN4521; GSK-3β inhibitor VIII; AR 014418) is a novel, potent, ATP-competitive, and selective inhibitor of GSK3β (Glycogen Synthase Kinase 3β) with the potential for neurodegenerative diseases. |
|
V0226 | IM-12 | 1129669-05-1 | IM-12, anindolylmaleimide analog, is a novel, potent, cell-permeable and selective inhibitor of GSK-3β (glycogen synthase kinase-3β) withpotential neuroprotective effects. |
|
V115878 | JGK-263 | 1408054-46-5 | JGK-263 is an orally effective glycogen synthase kinase-3β (GSK-3β) inhibitor. |
|
V0223 | LY2090314 | 603288-22-8 | LY2090314 (LY-2090314) is a novel and potent GSK-3 (glycogen synthase kinase-3) inhibitor for GSK-3α/β with potential antitumor activity. |
|
V0212 | SB216763 | 280744-09-4 | SB216763 is a novel, potent and selective GSK-3 (glycogen synthase kinase-3) inhibitor with anti-inflammatory activiity and neuro-protective effects as it canpromote DNA repair in ischemic retinal neurons. |
|
V0222 | TDZD-8 (NP-01139) | 327036-89-5 | TDZD-8(NP01139; GSK3 Inhibitor I) is a novel, potent and non-ATP competitive GSK-3β (glycogen synthase kinase-3beta) inhibitor with the potential for treating neurodegenerative diseases such as PD (parkinson disease). |
|
V0214 | TWS119 | 601514-19-6 | TWS119, apyrrolopyrimidine compound, is a novel, potent and selective/specific GSK-3β (Glycogen synthase kinase-3β) inhibitor with potentialusefulness for in vivo stem cell biology and therapy. |
|
V0211 | Laduviglusib (CHIR99021) | 252917-06-9 | Laduviglusib (CHIR-99021; CT99021; CT 99021) is a novel, potent and orally bioavailable inhibitor of GSK-3α/β (glycogen synthase kinase 3α/β) with the potential to treattype 2 diabetes. |
|
V2805 | Laduviglusib (CHIR-99021; CT99021) HCl | 1797989-42-4 | Laduviglusib (CHIR-99021; CT99021 or CHIR-911) HCl is the hydrochloride salt of CHIR-99021, which is a potent and orally available GSK-3α/β (glycogen synthase kinase 3α/β) inhibitor with IC50 of 10 nM/6.7 nM in cell-free assays; CHIR-99021 was proved to promote self-renewal and maintain pluripotency of both B6 and BALB/c ES cells via stabilizing the downstream effectors like c-Myc and β -catenin. |
|
V0215 | Tideglusib (NP-031112, NP-12) | 865854-05-3 | Tideglusib (formerly known as NP031112, NP12) is a novel, potent, irreversible, non-ATP-competitive and chemical inhibitor of GSK-3β (glycogen synthase kinase-3β) with potentialneuroprotective effects and may be used as an anti-AD (Alzheimer disease) agent. |
|
V0227 | Bikinin (Abrasin) | 188011-69-0 | Bikinin (also known as Abrasin), apyridinylamido compound, is a novel, potent, non-steroidal and ATP-competitive inhibitor of Arabidopsis GSK-3 (Glycogen synthase kinase 3). |
|
V0225 | Indirubin (NSC 105327; Couroupitine B) | 479-41-4 | Indirubin(also known as NSC-105327; Couroupitine B)is a potent and selective inhibitor of CDK (cyclin-dependent kinases) and GSK-3β(glycogen synthase kinase-3)with potential antitumor activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
